Abstract
Summary A Ni-catalyzed reductive cyclization of 1,6-dienes affords 3,4-disubstituted cyclopentane and pyrrolidine derivatives with high trans diastereoselectivity. This cyclization reaction enables the efficient synthesis of trans- 3,4-dimethyl gababutin, a pharmaceutical lead for treating neuropathic pain, and trans- 3,4-dimethylpyrrolidine, a precursor to drug candidates and pesticides. The trans selectivity distinguishes this reaction from relevant precedents that proceed via hydrogen-atom transfer and lead to cis products. Mechanistic investigation, including kinetic, spectroscopic, and radical clock studies, attributes the trans diastereoselectivity to a classic, organometallic catalytic cycle mediated by Ni(I) and Ni(III) intermediates. The electron-rich Ni(I) intermediate, stabilized by a redox-active α-diimine ligand, is responsible for the chemoselectivity toward reductive cyclization as opposed to the redox-neutral cycloisomerization observed with previous Ni(II) catalysts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.